The POSEIDON Criteria and Its Measure of Success Through the Eyes of Clinicians and Embryologists.
Esteves SC1, Alviggi C2, Humaidan P3,4, Fischer R5, Andersen CY6, Conforti A2, Bühler K7,8, Sunkara SK9, Polyzos NP10, Galliano D11, Grynberg M12, Yarali H13, Özbek IY13, Roque M14, Vuong LN15,16, Banker M17, Rienzi L18, Vaiarelli A18, Cimadomo D18, Ubaldi FM18
This article represents a viewpoint on the POSEIDON criteria by a group of clinicians and embryologists. Its primary objective is to contextualize the Poseidon criteria and their metric of success for the relevant Frontiers Research Topic "POSEIDON's Stratification of Low Prognosis Patients in ART: The WHY, the WHAT, and the HOW". "Low prognosis" relates with reduced oocyte number, which can be associated with low or sometimes a normal ovarian reserve and is aggravated by advanced female age. These aspects will ultimately affect the number of embryos generated and consequently, the cumulative live birth rate. The novel system relies on female age, ovarian reserve markers, ovarian sensitivity to exogenous gonadotropin, and the number of oocytes retrieved, which will both identify the patients with low prognosis and stratify such patients into one of four groups of women with "expected" or "unexpected" impaired ovarian response to exogenous gonadotropin stimulation. Furthermore, the POSEIDON group introduced a new measure of clinical success in ART, namely, the ability to retrieve the number of oocytes needed to obtain at least one euploid blastocyst for transfer in each patient. Using the POSEIDON criteria, the clinician can firstly identify and classify patients who have low prognosis in ART, and secondly, aim at designing an individualized treatment plan to maximize the chances of achieving the POSEIDON measure of success in each of the four low prognosis groups. The novel POSEIDON classification system is anticipated to improve counseling and management of low prognosis patients undergoing ART, with an expected positive effect on reproductive success and a reduction in the time to live birth.
ART calculator; POSEIDON criteria; assisted reproductive technology; blastocyst; low prognosis; oocyte; ovarian stimulation; poor ovarian response
Review Developing a core outcome set for future infertility research: an international consensus development study
[ J.M.N. Duffy 1,2,*, H. AlAhwany 3, S. Bhattacharya 4, B. Collura 5,C. Curtis 6,7, J.L.H. Evers 8, R.G. Farquharson 9, S. Franik 10, L.C. Giudice 11,12, Y. Khalaf 13, J.M.L. Knijnenburg 14, B. Leeners 15, R.S. Legro 16, S. Lensen 17, J.C. Vazquez-Niebla 18, D. Mavrelos 19, B.W.J. Mol 20, C. Niederberger 21, E.H.Y. Ng 22,23, A.S. Otter 24, L. Puscasiu 25, S. Rautakallio-Hokkanen 26, S. Repping 27, I. Sarris 1, J.L. Simpson 28, A. Strandell 29, C. Strawbridge 30, H.L. Torrance 31, A. Vail 32, M. van Wely 27, M.A. Vercoe 33, N.L. Vuong 34, A.Y. Wang 35, R. Wang 20, J. Wilkinson 32, M.A. Youssef 36, C.M. Farquhar 33, and the Core Outcome Measure for Infertility Trials (COMMIT) initiative ]
STUDY QUESTION: Can a core outcome set to standardize outcome selection, collection and reporting acr...
Review Antral follicle count and anti-Müllerian hormone to classify low-prognosis women under the POSEIDON criteria: a classification agreement study of over 9000 patients
[ Sandro C Esteves1, Hakan Yarali2,3, Lan N Vuong4,5,6, José F Carvalho7, İrem Y Özbek2, Mehtap Polat2, Ho L Le4,5, Toan D Pham4,5, Tuong M Ho4,5 ]
Review A cost-effectiveness analysis of freeze only or fresh embryo transfer in IVF of non-PCOS women
[ Le KD1, Vuong LN1,2, Ho TM1, Dang VQ1, Pham TD1, Pham CT3, Norman RJ4,5, Mol BWJ6. ]
Is a freeze-only strategy more cost-effective from a patient perspective than fresh embryo transfe...
Review Predictive Value of AMH, FSH and AFC for Determining Ovarian Response in Vietnamese Women Undergoing Assisted Reproductive Technologies: A Prospective Study
[ TNL Vuong1*, MT Vo1 and MT Ho2,3 ]
Background: There are comparatively few data on the value of different ovarian response predictors in conjunction with...
Review Cervical pessary vs vaginal progesterone for the prevention of preterm birth in women with twin pregnancies and a short cervix: an economic analysis alongside a randomized controlled trial
[ Le KD1, Nguyen LK2, Nguyen LTM2, Mol BWJ3, Dang VQ1,2 ]